Yttrium glass microsphere

Carr IB (2004) Hepatic arterial Yttrium glass microspheres (therasphere) for unresectable hepatocellular carcinoma interim safety and survival data on 65 patients. Liver Transplant 10 [Suppl 1] S107-S110... [Pg.148]

Yttrium(Y), 14 644, 645 Yttrium aluminosilicate (YAS) glass microspheres, 12 612 Yttrium aluminum garnet (YAG), 19 411 color, 7 331... [Pg.1031]

Wollner I, Knutsen C, Smith P et al (1988) Effects of hepatic arterial yttrium 90 glass microspheres in dogs. Cancer 61 1336-1344... [Pg.9]

Carr B, Salem R, Sheetz M et al (2002) Hepatic arterial yttrium labeled glass microspheres (TheraSphere) as treatment for unresectable HCC in 36 patients. Proceedings of ASCO 2002... [Pg.10]

Salem R, Lewandowski R, Roberts C et al (2004) Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vase Interv Radiol 15 335-345... [Pg.14]

Anderson JH, Goldberg JA, Bessent RG et al (1992) Glass yttrium-90 microspheres for patients with colorectal liver metastases. Radiother Oncol 25 137-139... [Pg.123]

Andrews JC, Walker SC, Ackermann RJ et al (1994) Hepatic radioembolization with yttrium-90 containing glass microspheres preliminary results and clinical follow-up. J Nucl Med 35 1637-1644... [Pg.123]

Yan ZP, Lin G, Zhao HY, Dong YH (1993) Yttrium-90 glass microspheres injected via the portal vein. An experimental study. Acta Radiol 34 395-398... [Pg.155]

Successful embolization of hepatocelluar carcinoma with yttrium-90 glass microspheres prior to liver transplantation. J Gastrointest Surg 10 413-416... [Pg.155]

Cao X et al. (1999) Hepatic radioembolization with yttrium-90 glass microspheres for the treatment of primary liver cancer. Chin Med J 112 430-432... [Pg.148]

As described in the product insert, TheraSphere consists of insoluble glass microspheres where Yttrium-90 is an integral constituent of the glass. [Pg.153]

As in the case for transarterial chemoemboliza-tion (FACE, Chapter 10), radioembolization takes advantage of the preferential hepatic arterial supply of hepatocellular carcinoma (HCC) to deliver targeted therapy to the tumor, relatively sparing the liver parenchyma, which is mostly supported by the portal venous system. Radioembolization is effected via intra-arterial delivery of carrier spheres onto which radioactive particles are attached. There are two types of radioactive microspheres that can be used in the treatment of primary (and metastatic for that matter) liver disease. They both contain Yttrium-90 ( °Y) as the active element but differ in the type of carrier particle. The first is Y glass... [Pg.141]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...